|
- 2018
伴有睡眠障碍帕金森病患者的睡眠特征及其影响因素
|
Abstract:
[1] | Bj?rnar? KA, Dietrichs E, Toft M. Clinical features associated with sleep disturbances in Parkinsons disease[J]. Clin Neurol Neurosurg, 2014, 124: 37-43. doi:10.1016/j.clineuro.2014.06.027. |
[2] | Targa AD, Rodrigues LS, Noseda AC, et al. Unraveling a new circuitry for sleep regulation in Parkinsons disease[J]. Neuropharmacology, 2016, 108: 161-171. |
[3] | Lima MM. Sleep disturbances in Parkinsons disease: the contribution of dopamine in REM sleep regulation[J]. Sleep Med Rev, 2013, 17(5): 367-375. |
[4] | Blesa J, Trigo-Damas I, Quiroga-Varela A, et al. Oxidative stress and Parkinsons disease[J]. Front Neuroanat, 2015, 9: 91. doi:10.3389/fnana.2015.00091. |
[5] | Rouault TA. Iron metabolism in the CNS: implications for neurodegenerative diseases[J]. Nat Rev Neurosci, 2013, 14(8): 551-564. |
[6] | 汪慧菁, 曲卫敏, 黄志力. 基底核中腺苷A2A受体和多巴胺D2受体调节睡眠-觉醒作用机制[J]. 世界睡眠医学杂志, 2014, 1(1): 23-29. WANG Huijing, QU Wemin, HUANG Zhili. The sleep-wake regulation of A2A receptor and D2 receptor in the basal ganglia[J]. World J of Sleep Medicine, 2014, 1(1): 23-29. |
[7] | Raggi A, Bella R, Pennisi G, et al. Sleep disorders in Parkinsons disease: a narrative review of the literature[J]. Rev Neurosci, 2013, 24(3): 279-291. |
[8] | Mariani S, Ventriglia M, Simonelli I, et al. Association between sex, systemic iron variation and probability of Parkinsons disease[J]. Neurosci, 2016, 126(4): 354-360. |
[9] | Medeiros MS, Schumacher-Schuh A, Cardoso AM, et al. Iron and oxidative stress in Parkinsons disease: an observational study of injury biomarkers[J]. PLoS One, 2016, 11(1): e146129. |
[10] | Costa-Mallen P, Zabetian CP, Agarwal P, et al. Haptoglobin phenotype modifies serum iron levels and the effect of smoking on Parkinson disease risk[J]. Parkinsonism Relat Disord, 2015, 21(9): 1087-1092. |
[11] | Albers JA, Chand P, Anch AM. Multifactorial sleep disturbance in Parkinsons disease[J]. Sleep Med, 2017, 35: 41-48. doi:10.1016/j.sleep.2017.03.026. |
[12] | Campolo J, De Maria R, Cozzi L, et al. Antioxidant and inflammatory biomarkers for the identification of prodromal Parkinsons disease[J]. J Neurol Sci, 2016, 370: 167-172. |
[13] | 王典茹, 黄志力, 曲卫敏. 视前正中核神经元调节睡眠-觉醒的研究进展[J]. 复旦学报(医学版), 2015, 42(6): 780-785. WANG Dianru, HUANG Zhili, QU Weimin. Advances in sleep-wake regulation of the median preoptic neucleus[J]. Fudan Univ J Med Sci, 2015, 42(6): 780-785. |
[14] | Villaran RF, Espinosa-Oliva AM, Sarmiento M, et al. Ulcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinsons disease[J]. Neurochem, 2010, 114(6): 1687-1700. |
[15] | Lindqvist D, Kaufman E, Brundin L, et al. Non-motor symptoms in patients with Parkinsons disease-correlations with inflammatory cytokines in serum[J]. PLoS One, 2012, 7(10): e47387. |
[16] | Virel A, Faergemann E, Oradd G, et al. Magnetic resonance imaging(MRI)to study striatal iron accumulation in a rat model of Parkinsons disease[J]. PLoS One, 2014, 9(11): e112941. |
[17] | Rhodes SL, Buchanan DD, Ahmed I, et al. Pooled analysis of iron-related genes in Parkinsons disease: association with transferrin[J]. Neurobiol Dis, 2014, 62: 172-178. |
[18] | Kutscher SJ, Farshidpanah S, Claassen DO. Sleep dysfunction and its management in Parkinsons disease[J]. Curr Treat Options Neurol, 2014, 16(8): 304. |
[19] | Xuan M, Guan X, Gu Q, et al. Different iron deposition patterns in early- and middle-late-onset Parkinsons disease[J]. Parkinsonism Relat Disord, 2017, 44: 23-27. doi:10.1016/j.parkreldis.2017.08.013. |
[20] | Hare DJ, Double KL. Iron and dopamine: a toxic couple[J]. Brain, 2016, 139(4): 1026-1035. |
[21] | Costa-Mallen P, Gatenby C, Friend S, et al. Brain iron concentrations in regions of interest and relation with serum iron levels in Parkinson disease[J]. Neurol Sci, 2017, 378: 38-44. |
[22] | Hu Y, Yu SY, Zuo LJ, et al. Investigation on abnormal iron metabolism and related inflammation in Parkinson disease patients with probable RBD[J]. PLoS One, 2015, 10(10): e138997. |